Cargando…
Monoclonal Antibodies Capable of Binding SARS-CoV-2 Spike Protein Receptor Binding Motif Specifically Prevent GM-CSF Induction.
A severe acute respiratory syndrome (SARS)-like coronavirus (SARS-CoV-2) has recently caused a pandemic COVID-19 disease that infected more than 25.6 million and killed 852,000 people worldwide. Like the SARS-CoV, SARS-CoV-2 also employs a receptor-binding motif (RBM) of its envelope spike protein f...
Autores principales: | Qiang, Xiaoling, Zhu, Shu, Li, Jianhua, Wang, Ping, Tracey, Kevin J., Wang, Haichao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480027/ https://www.ncbi.nlm.nih.gov/pubmed/32908979 http://dx.doi.org/10.1101/2020.09.04.280081 |
Ejemplares similares
-
Monoclonal antibodies capable of binding SARS‐CoV‐2 spike protein receptor‐binding motif specifically prevent GM‐CSF induction
por: Qiang, Xiaoling, et al.
Publicado: (2021) -
Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines
por: Li, Jianhua, et al.
Publicado: (2021) -
Identification of procathepsin L (pCTS-L)–neutralizing monoclonal antibodies to treat potentially lethal sepsis
por: Zhu, Cassie Shu, et al.
Publicado: (2023) -
Multiple autoantigen binding capabilities of mouse monoclonal antibodies selected for rheumatoid factor activity
Publicado: (1984) -
Granulocyte–macrophage colony‐stimulating factor (GM‐CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐GM‐CSF monoclonal antibody
por: Papp, K.A., et al.
Publicado: (2018)